Ontology highlight
ABSTRACT: Background
Complement-fixing antibodies are important mediators of protection against Plasmodium falciparum malaria. However, complement-fixing antibodies remain uncharacterized for Plasmodium vivax malaria. P. vivax merozoite surface protein 3α (PvMSP3α) is a target of acquired immunity and a potential vaccine candidate.Methods
Plasma from children and adults with P. vivax malaria in Sabah, Malaysia, were collected during acute infection, 7 and 28 days after drug treatment. Complement-fixing antibodies and immunoglobulin M and G (IgM and IgG), targeting 3 distinctive regions of PvMSP3α, were measured by means of enzyme-linked immunosorbent assay.Results
The seroprevalence of complement-fixing antibodies was highest against the PvMSP3α central region (77.6%). IgG1,
SUBMITTER: Oyong DA
PROVIDER: S-EPMC6834073 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature